International News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA Office of International Programs: OIP action plan will coordinate agency's international activities with "overall U.S. government objectives," Commissioner Mark McClellan says in Feb. 27 memo to agency employees. Charged with leading FDA efforts on embassy relations and trade agreements, the office will "leverage resources with counterpart agencies on a risk-benefit basis." Standard operating procedures will be developed in the coming weeks...
You may also be interested in...
Global Device Market Barriers, Strategies Detailed For U.S. Trade Report
Increased medical equipment import tariffs of up to 51% within India's 2002-2003 budget will add millions of dollars in costs for U.S. device companies, AdvaMed asserts in a Dec. 13 statement to the Office of the U.S. Trade Representative
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.